Contrastingly, Provenzano and colleagues have recently described a novel germline EGLN1 gene variant in a patient with metastatic PCC and chronic myeloid leukemia (CML) in the absence of polycythemia (98). The gene discussed is EGLN1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.